Restricted accessLetterFirst published online 2010-1
Management of hypertriglyceridaemia caused by combination antiretroviral therapy in HIV-infected patients: role of omega-3 polyunsaturated fatty acids at different dosages,compared with fibrates
FalascaK, UcciferriC, MancinoP, PizzigalloE, CalzaL, VecchietJ. Severe HIV-associated hypertriglyceridaemia treated with rosuvastatin plus omega-3 fatty acids. Int J STD AIDS2009;20:580–1
2.
ManfrediR, ChiodoF. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate. J Infect2001;42:181–8
3.
MetrokaCE, TruongP, GottoAMJr. Treatment of HIV-associated dyslipidemia: a role for omega-3 fatty acids. AIDS Read2007;17:362–4; 367–73
4.
ManfrediR, CalzaL. Valutazione diagnostica e trattamento della dislipidemia nel paziente in terapia HAART. Trends Med2007;7:55–69
5.
CalzaL, ManfrediR, ChiodoF. Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART. AIDS2003;17:851–9
6.
ManfrediR, CalzaL, ChiodoF. An extremely different dysmetabolic profile between the two available nonnucleoside reverse transcriptase inhibitors: efavirenz and nevirapine. J Acquir Immun Defic Syndr2005;38:236–8
7.
ManfrediR, CalzaL, ChiodoF. Polyunsaturated ethyl esters of n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapy. J Acquir Immun Defic Syndr2004;36:878–80
8.
RanieriR. Effect of omega-3 fatty acids on the lipid structure of HIV-positive patients on antiretroviral therapy: personal observation of 20 subjects. Infez Med2007;15:237–41
9.
WohlDA, TienHC, BusbyM, Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia. Clin Infect Dis2005;41:1505–6
10.
GerberJG, KitchDW, FichtenbaumCJ, Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. J Acquir Immun Defic Syndr2008;47:459–66
11.
JiangB, HebertVY, KhandelwalAR, StokesKY, DugasTR. HIV-1 antiretrovirals induce oxidant injury and increase intima-media thickness in an atherogenic mouse model. Toxicol Lett2009;187:164–71
12.
ManfrediR. High-risk dysmetabolism disorders associated with HAART-treated HIV disease, and reimbursement of lipid-lowering drugs, in a clinical and a socio-ecomomic perspective. AIDS Rev2005;7:155–60
